Tamsulosin retard Zentiva 0.4 mg
Tamsulosin retard Zentiva 0.4 mg is a medicine authorised by Swissmedic under authorisation number 67254. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 June 2019 and the authorisation is valid without a time limit. ATC code G04CA02 places the medicine in the group Urologicals.
| Authorisation number | 67254 |
|---|---|
| Name | Tamsulosin retard Zentiva 0.4 mg |
| Full name | Tamsulosin retard Zentiva 0.4 mg, Hartkapseln, retardiert |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G04CA02 |
| First authorisation | 19 June 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tamsulosin retard Zentiva 0.4 mg, Hartkapseln, retardiert | B | 19 June 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Kapsel(n) | G04CA02 | 05.99.0. | B |
| 2 | 30 | Kapsel(n) | G04CA02 | 05.99.0. | B |
| 3 | 100 | Kapsel(n) | G04CA02 | 05.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tamsulosin retard Zentiva 0.4 mg authorised in Switzerland?
Yes. Tamsulosin retard Zentiva 0.4 mg is authorised by Swissmedic under authorisation number 67254, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tamsulosin retard Zentiva 0.4 mg have?
Tamsulosin retard Zentiva 0.4 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Tamsulosin retard Zentiva 0.4 mg?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.